The benefits of HIV resistance testing in optimizing drug discovery.
作者信息
Heilek-Snyder Gabrielle, Bean Pamela
机构信息
Inflammatory and Viral Diseases Unit, Roche BioSciences, 3401 Hillview Ave., Palo Alto, CA 94304, USA.
出版信息
Am Clin Lab. 2002 Oct;21(8):13-4.
PMID:12440169
Abstract
摘要
相似文献
1
The benefits of HIV resistance testing in optimizing drug discovery.HIV耐药性检测在优化药物研发中的益处。
Am Clin Lab. 2002 Oct;21(8):13-4.
2
HIV drug resistance testing: an update for the clinician.
AIDS Clin Care. 2001 Oct;13(10):89-91, 94-6, 100.
3
Detection and significance of minority quasispecies of drug-resistant HIV-1.耐药性HIV-1少数准种的检测及其意义
J HIV Ther. 2006 Dec;11(4):74-81.
4
[Resistance investigations during HIV-therapy is necessary].
Dtsch Med Wochenschr. 1998 Feb 13;123(7):A7.
5
New insights into HIV resistance testing: nursing guidelines and implications.
J Assoc Nurses AIDS Care. 2007 May-Jun;18(3):74-86. doi: 10.1016/j.jana.2007.03.003.
6
Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.实验室工具在格鲁吉亚常规临床护理中成功应用于检测艾滋病毒耐药性。
Georgian Med News. 2008 Dec(165):16-22.
7
HIV drug resistance testing: data be damned.
Res Initiat Treat Action. 2000 Dec;6(4):25-7.
8
The K65R mutation: selection, frequency, and possible consequences.
AIDS Read. 2004 Nov;14(11):595-7, 601-3.
9
Update of the drug resistance mutations in HIV-1: 2004.2004年HIV-1耐药性突变的更新情况。
Top HIV Med. 2004 Oct-Nov;12(4):119-24.
10
[Incorporation of the test of resistance to antiretroviral drugs in clinical practice].
Med Clin (Barc). 1999 Mar 27;112(11):412-5.
Zotero 插件